121 related articles for article (PubMed ID: 28273902)
1. Botulinum hemagglutinin-mediated selective removal of cells deviating from the undifferentiated state in hiPSC colonies.
Kim MH; Sugawara Y; Fujinaga Y; Kino-Oka M
Sci Rep; 2017 Mar; 7(1):93. PubMed ID: 28273902
[TBL] [Abstract][Full Text] [Related]
2. A Simple and Robust Method for Culturing Human-Induced Pluripotent Stem Cells in an Undifferentiated State Using Botulinum Hemagglutinin.
Kim MH; Matsubara Y; Fujinaga Y; Kino-Oka M
Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 29027750
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of an undifferentiated state of human-induced pluripotent stem cells through botulinum hemagglutinin-mediated regulation of cell behavior.
Shuzui E; Kim MH; Azuma K; Fujinaga Y; Kino-Oka M
J Biosci Bioeng; 2019 Jun; 127(6):744-751. PubMed ID: 30660482
[TBL] [Abstract][Full Text] [Related]
4. Anomalous cell migration triggers a switch to deviation from the undifferentiated state in colonies of human induced pluripotent stems on feeder layers.
Shuzui E; Kim MH; Kino-Oka M
J Biosci Bioeng; 2019 Feb; 127(2):246-255. PubMed ID: 30224190
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of deviation from the undifferentiated state in colonies of human induced pluripotent stem cells on feeder layers.
Kim MH; Masuda E; Kino-oka M
Biotechnol Bioeng; 2014 Jun; 111(6):1128-38. PubMed ID: 24420640
[TBL] [Abstract][Full Text] [Related]
6. Growth prolongation of human induced pluripotent stem cell aggregate in three-dimensional suspension culture system by addition of botulinum hemagglutinin.
Yamamoto R; Sakakibara R; Kim MH; Fujinaga Y; Kino-Oka M
J Biosci Bioeng; 2024 Feb; 137(2):141-148. PubMed ID: 38110319
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of undifferentiated state of human induced pluripotent stem cells through cytoskeleton-driven force acting to secreted fibronectin on a dendrimer-immobilized surface.
Kim MH; Kino-oka M
J Biosci Bioeng; 2014 Dec; 118(6):716-22. PubMed ID: 24947748
[TBL] [Abstract][Full Text] [Related]
8. Botulinum hemagglutinin-mediated in situ break-up of human induced pluripotent stem cell aggregates for high-density suspension culture.
Nath SC; Tokura T; Kim MH; Kino-Oka M
Biotechnol Bioeng; 2018 Apr; 115(4):910-920. PubMed ID: 29278408
[TBL] [Abstract][Full Text] [Related]
9. Nanotopographical control for maintaining undifferentiated human embryonic stem cell colonies in feeder free conditions.
Bae D; Moon SH; Park BG; Park SJ; Jung T; Kim JS; Lee KB; Chung HM
Biomaterials; 2014 Jan; 35(3):916-28. PubMed ID: 24183167
[TBL] [Abstract][Full Text] [Related]
10. Elimination of cells deviated from human induced pluripotent stem cells with a photoactivatable IR700-labelled antibody.
Watanabe T; Tateno H
Biochem Biophys Res Commun; 2021 May; 554():13-18. PubMed ID: 33774274
[TBL] [Abstract][Full Text] [Related]
11. Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin.
Sugawara Y; Matsumura T; Takegahara Y; Jin Y; Tsukasaki Y; Takeichi M; Fujinaga Y
J Cell Biol; 2010 May; 189(4):691-700. PubMed ID: 20457762
[TBL] [Abstract][Full Text] [Related]
12. ROCK inhibitor primes human induced pluripotent stem cells to selectively differentiate towards mesendodermal lineage via epithelial-mesenchymal transition-like modulation.
Maldonado M; Luu RJ; Ramos ME; Nam J
Stem Cell Res; 2016 Sep; 17(2):222-227. PubMed ID: 27591478
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the treatment conditions with glycogen synthase kinase-3 inhibitor towards enhancing the proliferation of human induced pluripotent stem cells while maintaining an undifferentiated state under feeder-free conditions.
Yoda K; Ohnuki Y; Kurosawa H
J Biosci Bioeng; 2019 Mar; 127(3):381-387. PubMed ID: 30292671
[TBL] [Abstract][Full Text] [Related]
14. A Novel Strategy for Simple and Robust Expansion of Human Pluripotent Stem Cells Using Botulinum Hemagglutinin.
Kim MH; Kino-Oka M
Adv Exp Med Biol; 2018; 1077():19-29. PubMed ID: 30357681
[TBL] [Abstract][Full Text] [Related]
15. A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells.
Jin S; Yao H; Weber JL; Melkoumian ZK; Ye K
PLoS One; 2012; 7(11):e50880. PubMed ID: 23226418
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide induces apoptosis in undifferentiated human induced pluripotent stem cells.
Tachikawa S; Nishimura T; Nakauchi H; Ohnuma K
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):841-851. PubMed ID: 28849348
[TBL] [Abstract][Full Text] [Related]
17. Switching between self-renewal and lineage commitment of human induced pluripotent stem cells via cell-substrate and cell-cell interactions on a dendrimer-immobilized surface.
Kim MH; Kino-oka M
Biomaterials; 2014 Jul; 35(22):5670-8. PubMed ID: 24746960
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of an undifferentiated state of human induced pluripotent stem cells through migration-dependent regulation of the balance between cell-cell and cell-substrate interactions.
Kim MH; Kino-oka M
J Biosci Bioeng; 2015 Jun; 119(6):617-22. PubMed ID: 25468424
[TBL] [Abstract][Full Text] [Related]
19. Modulation of integrin and E-cadherin-mediated adhesions to spatially control heterogeneity in human pluripotent stem cell differentiation.
Toh YC; Xing J; Yu H
Biomaterials; 2015 May; 50():87-97. PubMed ID: 25736499
[TBL] [Abstract][Full Text] [Related]
20. Adhesion, but not a specific cadherin code, is indispensable for ES cell and induced pluripotency.
Bedzhov I; Alotaibi H; Basilicata MF; Ahlborn K; Liszewska E; Brabletz T; Stemmler MP
Stem Cell Res; 2013 Nov; 11(3):1250-63. PubMed ID: 24036274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
